Loiacono Michael 4
4 · Marker Therapeutics, Inc. · Filed Mar 12, 2020
Insider Transaction Report
Form 4
Loiacono Michael
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-10+20,900→ 20,900 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (20,900 underlying) - Award
Employee Stock Option (Right to Buy)
2020-03-10+119,100→ 119,100 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (119,100 underlying)
Footnotes (2)
- [F1]Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
- [F2]This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.